The In Vitro Lipolysis of Lipid-Based Drug Delivery Systems: A Newly Identified Relationship between Drug Release and Liquid Crystalline Phase

Table 2

Equilibrium solubility at 37°C, the particle size of dispersion, and polydispersity index of the lipid formulation (, the average value was used).

Type	Equilibrium solubility of indomethacin in lipid formulation (mg·g^−1)	-Ave (nm)	PDI
Type I	12.17	coarse	N/A
Type II	32.19	130.20	0.28
Type IIIA	68.89	57.14	0.33
Type IIIB	108.60	14.55	0.20
Type IV	100.39	12.21	0.19